Live Breaking News & Updates on Mbio

Stay informed with the latest breaking news from Mbio on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mbio and stay connected to the pulse of your community

Alpine Immune Sciences (NASDAQ:ALPN) and Mustang Bio (NASDAQ:MBIO) Critical Survey

Mustang Bio (NASDAQ:MBIO – Get Free Report) and Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk. Valuation and Earnings This table compares […]

Worcester , Massachusetts , United-states , Washington , Seattle , Mayo-clin , Mustang-bio-inc , Alpine-immune-sciences-inc , Leiden-university-medical-centre , Alpine-immune-sciences , Mustang-bio , Get-free-report

Mustang Bio (MBIO) to Release Quarterly Earnings on Tuesday

Mustang Bio (NASDAQ:MBIO – Get Free Report) is scheduled to be posting its quarterly earnings results on Tuesday, November 14th. Mustang Bio (NASDAQ:MBIO – Get Free Report) last posted its quarterly earnings data on Monday, August 14th. The company reported ($2.00) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.07) by […]

Renaissance-technologies , Vanguard-group-inc , Mustang-bio-company-profile , Millennium-management , Mustang-bio-inc , Asset-group-inc , Hightower-advisors , Cantor-fitzgerald , Mustang-bio , Get-free-report , Bio-stock-down

Mustang Bio (MBIO) Set to Announce Earnings on Tuesday

Mustang Bio (NASDAQ:MBIO – Get Free Report) will announce its earnings results on Tuesday, November 14th. Mustang Bio (NASDAQ:MBIO – Get Free Report) last issued its quarterly earnings results on Monday, August 14th. The company reported ($2.00) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.07) by $0.07. On average, analysts […]

Envestnet-asset-management-inc , Barclays-plc , Cantor-fitzgerald , Mustang-bio-inc , Virtu-financial , Cetera-advisor-networks , Mustang-bio-company-profile , Mustang-bio , Get-free-report , Bio-trading-down , Advisor-networks

Mustang Bio, Inc. (NASDAQ:MBIO) Sees Large Growth in Short Interest

Mustang Bio, Inc. (NASDAQ:MBIO – Get Free Report) saw a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 186,700 shares, a growth of 571.6% from the October 15th total of 27,800 shares. Based on an average daily trading volume, of 75,700 shares, the days-to-cover […]

Mustang-bio-company-profile , Millennium-management , Hightower-advisors , Virtu-financial , Asset-group-inc , Envestnet-asset-management-inc , Mustang-bio-inc , Nasdaq , Cantor-fitzgerald , Mustang-bio , Get-free-report

MBIO Stock Price | Mustang Bio Inc. Stock Quote (U.S.: Nasdaq)

MBIO | Complete Mustang Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Etby-tomi-kilgore , Jude-children-research-hospital , Mustang-bio-inc , Mustang-bio , Jude-children , Research-hospital , Mbio , Bio-analyst-estimates , Bio-earnings-estimates , Bio-share-estimates , Bio-analyst-recommendations , Bio-ratings

Mustang Bio Shares Rise 13% After FDA Acceptance of IND Application

By Chris Wack Mustang Bio shares were up 13% at $1.77 after the company received U.S. Food and Drug Administration acceptance for its Investigational New...

Chris-wack , University-of-alabama-at-birmingham , Drug-administration , Investigational-new-drug , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision , Regulation-government-policy

Mustang Bio Shares Down 12% After Direct Offering Prices

By Chris Wack Mustang Bio shares reversed course in midday trading after the company priced a $4.4 million direct offering. The stock was recently down 12%...

Chris-wack , Drug-administration , Investigational-new-drug , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision , Financial-performance , Share-price-movement-disruptions

Mustang Bio's (MBIO) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Mustang Bio (NASDAQ:MBIO – Free Report) in a research report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $18.00 price objective on the stock. MBIO has been the topic of several other research reports. HC Wainwright restated a buy rating and set a […]

Hightower-advisors , Mustang-bio-company-profile , Mustang-bio-inc , Millennium-management , Cantor-fitzgerald , Asset-group-inc , Envestnet-asset-management-inc , Virtu-financial , Mustang-bio , Free-report , Bio-stock-down

Short Interest in Mustang Bio, Inc. (NASDAQ:MBIO) Decreases By 19.9%

Mustang Bio, Inc. (NASDAQ:MBIO – Get Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 34,600 shares, a decrease of 19.9% from the July 31st total of 43,200 shares. Currently, 0.6% of the company’s stock are sold short. […]

B-riley-wealth-advisors-inc , Arete-wealth-advisors , Asset-group-inc , Barclays-plc , Koss-olinger-consulting , Nasdaq , Mustang-bio-inc , Cantor-fitzgerald , Mustang-bio , Get-free-report , Olinger-consulting

Mustang Bio (MBIO) to Release Earnings on Friday

Mustang Bio (NASDAQ:MBIO – Get Free Report) will post its quarterly earnings results on Friday, August 11th. Mustang Bio (NASDAQ:MBIO – Get Free Report) last issued its quarterly earnings results on Friday, May 12th. The company reported ($2.06) earnings per share for the quarter, beating the consensus estimate of ($2.85) by $0.79. On average, analysts […]

Renaissance-technologies , Millennium-management , Asset-group-inc , Vanguard-group-inc , Nasdaq , Mustang-bio-inc , Mustang-bio-company-profile , Hightower-advisors , Mustang-bio , Get-free-report , Bio-stock-down